Education
About Us
Working with TipRanks
Follow Us
AIM ImmunoTech (AIM)
:AIM
Total Valuation
AIM ImmunoTech has a market cap or net worth of $6.99M. The enterprise value is $8.54M.
Market Cap$6.99M
Enterprise Value$8.54M
Share Statistics
AIM ImmunoTech has 2,708,688 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,708,688
Owned by Insiders4.62%
Owned by Institutions0.19%
Financial Efficiency
AIM ImmunoTech’s return on equity (ROE) is 13.10 and return on invested capital (ROIC) is -1221.25%.
Return on Equity (ROE)13.10
Return on Assets (ROA)-2.01
Return on Invested Capital (ROIC)-1221.25%
Return on Capital Employed (ROCE)21.33
Revenue Per Employee8.10K
Profits Per Employee-824.76K
Employee Count21
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AIM ImmunoTech is ―. AIM ImmunoTech’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value-847.46
Price to FCF―
Price to Operating Cash Flow-11.86
PEG Ratio―
Income Statement
In the last 12 months, AIM ImmunoTech had revenue of 170.00K and earned -17.32M in profits. Earnings per share was -0.31.
Revenue170.00K
Gross Profit139.00K
Operating Income-19.77M
Pretax Income-17.32M
Net Income-17.32M
EBITDA-16.49M
Earnings Per Share (EPS)-0.31
Cash Flow
In the last 12 months, operating cash flow was -10.96M and capital expenditures -560.00K, giving a free cash flow of -11.52M billion.
Operating Cash Flow-10.96M
Free Cash Flow-11.52M
Free Cash Flow per Share-4.25
Dividends & Yields
AIM ImmunoTech pays an annual dividend of $0.272, resulting in a dividend yield of ―
Dividend Per Share$0.272
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.42
52-Week Price Change-93.05%
50-Day Moving Average6.18
200-Day Moving Average12.29
Relative Strength Index (RSI)26.87
Average Volume (3m)319.45K
Important Dates
AIM ImmunoTech upcoming earnings date is Nov 14, 2025, TBA (Confirmed).
Last Earnings DateAug 15, 2025
Next Earnings DateNov 14, 2025
Ex-Dividend Date―
Financial Position
AIM ImmunoTech as a current ratio of 0.44, with Debt / Equity ratio of -65.39%
Current Ratio0.44
Quick Ratio0.44
Debt to Market Cap<0.01
Net Debt to EBITDA-0.08
Interest Coverage Ratio-33.80
Taxes
In the past 12 months, AIM ImmunoTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AIM ImmunoTech EV to EBITDA ratio is -68.02, with an EV/FCF ratio of -75.24.
EV to Sales6.60K
EV to EBITDA-68.02
EV to Free Cash Flow-75.24
EV to Operating Cash Flow-75.33
Balance Sheet
AIM ImmunoTech has $835.00K in cash and marketable securities with $2.81M in debt, giving a net cash position of $1.97M billion.
Cash & Marketable Securities$835.00K
Total Debt$2.81M
Net Cash$1.97M
Net Cash Per Share$0.73
Tangible Book Value Per Share-$0.07
Margins
Gross margin is 77.40%, with operating margin of -11630.59%, and net profit margin of -10188.24%.
Gross Margin77.40%
Operating Margin-11630.59%
Pretax Margin-10188.24%
Net Profit Margin-10188.24%
EBITDA Margin-9699.41%
EBIT Margin-9844.12%
Analyst Forecast
The average price target for AIM ImmunoTech is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target$2.50
Price Target Upside0.00%
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast-39.80%
EPS Growth Forecast56.07%